Last $59.31 USD
Change Today -0.368 / -0.62%
Volume 93.2K
CRL On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 12:21 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William H. Waltrip

Director, Chairman of Nominating/Corporate Governance Committee and Member of Audit Committee, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 6 different industries.

See Board Relationships
76$388,507

Background*

Mr. William H. Waltrip served as the Chairman of Bausch & Lomb Incorporated from 1995 to 1998 and served as its Chief Executive Officer in during 1996. Mr. Waltrip served twice as Bausch & Lomb's interim Chief Executive Officer, since 1996 and again since 2001. Mr. Waltrip served as the Chief Executive Officer of Technology Solutions Company from June 1993 to June 1995. From 1991 to 1993, Mr. Waltrip served as the Chairman of the Board and Chief Executive Officer of ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: --

Board Members Memberships*

Trustee
Former Trustee of Teachers Insurance and Annuity Association of America
Director, Chairman of Corporate Goveranance & Nominating Committee, Member of Audit Committee, Member of Compensation Committee and Member of Executive Committee
1983-2011
Former Independent Director, Member of Executive Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
1985-N/A
Former Lead Director, Chairman of Nominating & Governance Committee, Member of Compensation Committee and Member of Executive Committee
1990-N/A
Former Director
1992-2003
Former Chairman of the Board
1996-2013
Former Lead Independent Director, Chairman of Compensation Committee, Member of Executive Committee and Member of Corporate Governance & Nominating Committee
2000-Present
Director, Chairman of Nominating/Corporate Governance Committee and Member of Audit Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$111,000
Total Calculated Compensation$388,507
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $59.31 USD -0.368

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
823.0K GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.